Vulvovaginal Atrophy
Showing 1 - 25 of 43
Vulvovaginal Atrophy Trial in Ankara (Hyaluronic acid vaginal gel, Estrogen vaginal use form)
Completed
- Vulvovaginal Atrophy
- Hyaluronic acid vaginal gel
- Estrogen vaginal use form
-
Ankara, Çankaya, TurkeyTurkey
Nov 17, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial
Withdrawn
- Anatomic Stage 0 Breast Cancer AJCC v8
- +28 more
- Carbon Dioxide Fractional Laser
- Questionnaire Administration
- (no location specified)
Jan 5, 2023
Vulvovaginal Atrophy, Vasomotor Symptoms Trial in Adelaide, Nedlands (IVR Dose 1, IVR Dose 2)
Active, not recruiting
- Vulvovaginal Atrophy
- Vasomotor Symptoms
- IVR Dose 1
- IVR Dose 2
-
Adelaide, Southern Australia, Australia
- +1 more
Dec 6, 2022
Vulvovaginal Atrophy, Vasomotor Symptoms Trial in Melbourne, Nedlands (IVR Dose 1, IVR Dose 2, Oral Reference)
Completed
- Vulvovaginal Atrophy
- Vasomotor Symptoms
- IVR Dose 1
- +2 more
-
Melbourne, Australia
- +1 more
Dec 6, 2022
Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause Trial in Stockholm (vaginal estradiol 10 µg, vaginal DHEA 6.5 mg)
Recruiting
- Vulvovaginal Atrophy
- Genitourinary Syndrome of Menopause
- vaginal estradiol 10 μg
- vaginal DHEA 6.5 mg
-
Stockholm, SwedenKarolinska University Hospital
Oct 15, 2022
Vulvovaginal Atrophy, Breast Cancer Trial in Gent (Estrogen, dehydroepiandrosterone, Estrogen + probiotics)
Recruiting
- Vulvovaginal Atrophy
- Breast Cancer
- Estrogen
- +3 more
-
Gent, BelgiumUniversity Hospital Ghent
Sep 28, 2022
Vulvovaginal Atrophy Trial in United States (Vehicle, WC3011 Estradiol Vaginal Cream)
Completed
- Vulvovaginal Atrophy
- Vehicle
- WC3011 Estradiol Vaginal Cream
-
Huntsville, Alabama
- +47 more
Apr 11, 2022
Vulvovaginal Atrophy Trial in United States (WC3011 Estradiol Vaginal Cream)
Completed
- Vulvovaginal Atrophy
- WC3011 Estradiol Vaginal Cream
-
Huntsville, Alabama
- +63 more
Apr 11, 2022
Vulvovaginal Atrophy Questionnaire: Psychometric Validation
Not yet recruiting
- Vulvovaginal Atrophy
- +2 more
- (no location specified)
Apr 8, 2022
Vulvovaginal Atrophy Trial in Pavia, Madrid (Venus Fiore Study Treatment, Venus Fiore Sham Treatment)
Active, not recruiting
- Vulvovaginal Atrophy
- Venus Fiore Study Treatment
- Venus Fiore Sham Treatment
-
Pavia, Italy
- +1 more
Feb 15, 2022
Vulvovaginal Atrophy, Menopause, Menopause Surgical Trial in White Rock, Markham, Toronto (Vulvovaginal treatment, Baseline)
Active, not recruiting
- Vulvovaginal Atrophy
- +2 more
- Vulvovaginal treatment
- Baseline
-
White Rock, British Columbia, Canada
- +2 more
Feb 15, 2022
Vulvovaginal Atrophy, Menopause, Menopause Surgical Trial in Markham (Vulvovaginal Treatment)
Recruiting
- Vulvovaginal Atrophy
- +2 more
- Vulvovaginal Treatment
-
Markham, Ontario, CanadaDr. George Arnold
Feb 15, 2022
Vulvovaginal Atrophy Trial in Leuven (Vaginal laser application)
Completed
- Vulvovaginal Atrophy
- Vaginal laser application
-
Leuven, BelgiumUZ Leuven
Jan 6, 2022
Vulvovaginal Atrophy Trial in Schenefeld (WO533)
Completed
- Vulvovaginal Atrophy
-
Schenefeld, GermanyproDERM Institute for Applied Dermatological Research
Dec 22, 2021
Vulvovaginal Atrophy Trial in Barcelona, Madrid (Idracare)
Recruiting
- Vulvovaginal Atrophy
- Idracare
-
Barcelona, Spain
- +1 more
Aug 16, 2021
Female Sexual Function, Vulvovaginal Atrophy, Postmenopausal Atrophic Vaginitis Trial in Pathum Wan (Visnadin, ethyl ximeninate,
Recruiting
- Female Sexual Function
- +2 more
- Visnadin, ethyl ximeninate, coleus barbatus and millet in emulgel
- Emulgel-only
-
Pathum Wan, Bangkok, ThailandFaculty of Medicine, Chulalongkorn University
Aug 4, 2021
Women's Satisfaction and Adherence to Vulvovaginal Atrophy
Completed
- Vulvovaginal Atrophy
-
Barcelona, Spain
- +2 more
Jun 18, 2021
Vulvovaginal Atrophy Trial in Palo Alto, West Chester (Laser treatment)
Completed
- Vulvovaginal Atrophy
- Laser treatment
-
Palo Alto, California
- +1 more
May 11, 2021
Vulvovaginal Atrophy Trial in Madrid (Prasterone 6.5 MG, Placebo)
Recruiting
- Vulvovaginal Atrophy
- Prasterone 6.5 MG
- Placebo
-
Madrid, SpainInstituto Palacios
May 28, 2021
Vulvovaginal Atrophy Trial in Madrid (Estradiol 10 MCG Vaginal Tablet [VAGIFEM], Promestriene Vaginal)
Completed
- Vulvovaginal Atrophy
- Estradiol 10 MCG Vaginal Tablet [VAGIFEM]
- Promestriene Vaginal
-
Madrid, SpainInstituto Palacios
Feb 10, 2021
Vulvovaginal Atrophy Trial in Brescia, Milan, Pavia (Celegyn®, Matching )
Unknown status
- Vulvovaginal Atrophy
- Celegyn®
- Matching placebo
-
Brescia, Italy
- +2 more
Jan 5, 2021
Vulvovaginal Atrophy Trial in Huddinge, Umeå, Uppsala (Oxytocin 400 IU vaginal gel, Placebo)
Completed
- Vulvovaginal Atrophy
- Oxytocin 400 IU vaginal gel
- Placebo
-
Huddinge, Sweden
- +2 more
Nov 10, 2020
Vulvovaginal Atrophy Trial (Estrogen vaginal cream group (group A), Photobiomodutation group (group B))
Unknown status
- Vulvovaginal Atrophy
- Estrogen vaginal cream group (group A)
- Photobiomodutation group (group B)
- (no location specified)
Nov 9, 2020
Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy, Menopause Trial in Kyiv (Radiofrequency and pulsed electro-magnetic
Completed
- Genitourinary Syndrome of Menopause
- +2 more
- Radiofrequency and pulsed electro-magnetic fields treatment
-
Kyiv, UkraineCogerent Laser Clinics Group
Oct 22, 2020